or Try an Advanced Search...

    Technical Analysis for MRNA - Moderna, Inc.

    Grade Last Price % Change Price Change
    D 103.29 3.01% 3.02
    MRNA closed up 3.01 percent on Friday, September 29, 2023, on approximately normal volume.
    130 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Up
    Historical MRNA trend table...
    Date Alert Name Type % Chg
    Gapped Up Strength 0.00%
    Up 3 Days in a Row Strength 0.00%
    Oversold Stochastic Weakness 0.00%
    Multiple of Ten Bullish Other 3.01%
    Outside Day Range Expansion 3.01%
    Oversold Stochastic Weakness 3.01%
    Spinning Top Other 3.87%
    Multiple of Ten Bearish Other 3.87%
    Outside Day Range Expansion 3.87%
    Oversold Stochastic Weakness 3.87%
    Older End-of-Day Signals for MRNA ...

       Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

    Alert Time
    Up 1 ATR 1 day ago
    60 Minute Opening Range Breakout 1 day ago
    Up 3% 1 day ago
    Rose Above Previous Day's High 1 day ago
    Rose Above 10 DMA 1 day ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    MRNA Chart by TradingView
    Basic chart:

    Profile

    Moderna, Inc. develops medicines based on messenger RNA (mRNA). Its pipeline includes development candidates for mRNA-based vaccines and therapies for use in various therapeutic areas comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: S&P 500 Cancer Life Sciences Biology Nasdaq 100 Vaccines Coronavirus RNA Cancer Vaccine Messenger RNA

    Is MRNA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Sep 29 Moderna Recommends Shareholders Reject Amended “Mini-Tender” Offer by TRC Capital Investment Corporation
    Sep 29 If I Could Only Buy 3 Stocks in 2023, I'd Pick These
    Sep 29 Is it Time to Buy Pfizer, Moderna, or AstraZeneca's Stock?
    Sep 28 Moderna (MRNA) Outpaces Stock Market Gains: What You Should Know
    Sep 28 Covid-19 Vaccine Uptake Could Beat Expectations, Poll Indicates
    Sep 27 Mainz Biomed To Present The Power Of mRNA That Promises To Revolutionize Medicine
    Sep 27 Apple Defends Its $19B Google Search Deal, Hollywood's Writers Secure Credit For AI Training, China's Ambitious Chip Fund Faces Headwinds: Today's Top Stories
    Sep 26 Moderna Talks Offer Hope for Enhanced COVID-19 Vaccine Availability In Europe
    Sep 26 US STOCKS-Wall St poised for weak open as rate worries keep Treasury yields elevated
    Sep 26 UPDATE 2-EU in talks with Moderna over new deal for COVID vaccines - FT
    See more MRNA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 217.25
    52 Week Low 95.02
    Average Volume 3,889,603
    200-Day Moving Average 140.28
    50-Day Moving Average 108.62
    20-Day Moving Average 105.36
    10-Day Moving Average 101.39
    Average True Range 4.20
    RSI (14) 45.95
    ADX 20.65
    +DI 21.49
    -DI 26.20
    Chandelier Exit (Long, 3 ATRs) 105.48
    Chandelier Exit (Short, 3 ATRs) 109.70
    Upper Bollinger Bands 115.08
    Lower Bollinger Band 95.63
    Percent B (%b) 0.39
    BandWidth 18.46
    MACD Line -2.81
    MACD Signal Line -2.42
    MACD Histogram -0.3935
    Fundamentals Value
    Market Cap 40.87 Billion
    Num Shares 396 Million
    EPS -2.35
    Price-to-Earnings (P/E) Ratio -43.99
    Price-to-Sales 233.14
    Price-to-Book 22.55
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 108.33
    Resistance 3 (R3) 108.23 106.45 107.49
    Resistance 2 (R2) 106.45 105.17 106.50 107.21
    Resistance 1 (R1) 104.87 104.37 105.66 104.97 106.93
    Pivot Point 103.09 103.09 103.49 103.14 103.09
    Support 1 (S1) 101.51 101.81 102.30 101.61 99.65
    Support 2 (S2) 99.73 101.01 99.78 99.37
    Support 3 (S3) 98.15 99.73 99.09
    Support 4 (S4) 98.25